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Most vaccines aim at inducing durable antibody responses and are designed to elicit
strong B cell activation and plasma cell (PC) formation. Here we report characteristics
of a recently described secondary PC population that rapidly originates from memory
B cells (MBCs) upon challenge with virus-like particles (VLPs). Upon secondary antigen
challenge, all VLP-specific MBCs proliferated and terminally differentiated to secondary
PCs or died, as they could not undergo multiple rounds of re-stimulation. Secondary PCs
lived in bonemarrow and secondary lymphoid organs and exhibited increased production
of antibodies with much higher avidity compared to primary PCs, supplying a swift wave
of high avidity antibodies early after antigen recall. Unexpectedly, however, secondary
PCs were functionally short-lived and most of them could not be retrieved in lymphoid
organs and ceased to produce antibodies. Nevertheless, secondary PCs are an early
source of high avidity antibodies and induction of long-lived MBCs with the capacity to
rapidly differentiate to secondary PCs may therefore be an underestimated possibility to
induce durable protection by vaccination.
Keywords: adaptive immunity, anti-viral immunity, memory B cells, secondary plasma cells, virus-like particles
INTRODUCTION
B cells differentiate to antibody secreting plasma cells (PCs) upon activation by their cognate
antigen (Ag) within and outside of B cell follicles. At an early stage of the primary immune response,
antibody–forming cells (AFCs) derived from follicular or marginal zone (MZ) B cells are rather
short-lived and survive for a few days only (1). Meanwhile, follicular B cells form GCs where MBCs
and long-lived PCs are generated in a mostly T cell dependent fashion (2–5).
Activated B-lymphocytes are driven to the PC pathway by up-regulation of the transcription
factors B lymphocyte maturation protein 1 (Blimp-1), Interferon regulating protein 4 (IRF 4),
and X-box-binding protein 1 (XBP 1) (6–8). Differentiation of activated B cells into AFCs needs
a harmonized change in the gene expression of these cells. Shi et al. delineated the transcriptional
profile during this differentiation process (9). PCs are terminally differentiated and arrested in the
G1 phase of the cell cycle being incapable of further growth or proliferation (10, 11). To be able
to secrete large amounts of antibodies, PCs are committed to their protein synthesizing machinery
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and undergo major structural adaptations by increasing the size
of the endoplasmic reticulum and Golgi apparatus (12). To
cope with these changing conditions PCs induce the unfolded
protein response as well as autophagy (13–15). These stress-
regulating processes are necessary for survival as PCs can secrete
the tremendous amount of up to 10’000 antibodies per second
(16). Sizeable amounts of antibodies that are rapidly available
are required to neutralize microorganisms and prevent infection.
Antibodies furthermore play a key role in immunity and promote
the crosstalk between the innate and adaptive immune system.
Besides classical neutralization of toxins and pathogens, they are
able to opsonize microbes and infected cells for phagocytosis,
enabling their elimination, and promote antigen presentation
thereby regulating inflammation (17).
PCs are found in secondary lymphoid organs and the bone
marrow (BM) where they can survive for days, months, or
even years. There is an ongoing debate whether long-term
antibody responses are a result of persisting antigen leading
to re-stimulation and differentiation of memory B cells to PCs
or whether they are derived from intrinsically long-lived PCs.
Several studies are in favor of the first hypothesis that persistent
antigen or infection and polyclonal memory B cell activation
is required (18–22). Nevertheless, evidence is growing that PCs
can persist in the absence of continuous stimulation (23–25). It
was shown that PCs require cell-intrinsic and extrinsic survival
signals such as cytokines and adhesion molecules from nursery
cells like monocytes, eosinophils, and megakaryocytes for long-
term survival in BM niches (26–29). Once they reach the BM
and successfully compete for a niche, PCs have a lifespan varying
from a few months to years and even decades during which
they constantly secrete antibodies (30, 31). In contrast to PCs,
which do not express surface Ig, MBCs respond to secondary Ag
encounter. They exhibit the intrinsic ability to respond with a
proliferative burst faster compared to naïve B cells (32) and were
found to seed new GCs and/or differentiate into PCs (33–37).
Antibody responses generated during secondary responses are
usually of higher affinity for the cognate Ag compared to those
of a primary response.
We have previously shown that immunization with VLPs
derived from the RNA bacteriophage Qβ elicit strong and
sustained IgG antibody responses by activation of MZ and
follicular B cells with the latter forming GCs (38–40). MBCs
and PCs were rapidly generated and detectable as early as 3
days and up to several months after immunization in spleen
and BM (41, 42). Here we show, that MBCs generated against
Qβ proliferated during Ag recall experiments but exclusively
differentiated into secondary PCs and failed to respond to
multiple rounds of Ag stimulation. Secondary PCs exhibited the
unique ability to produce 30 times more antibodies of increased
affinity compared to primary PCs. The secondary PCs were
found in spleen as well as in BM early on day 4 but almost
completely disappeared by day 6 after Ag re-encounter from
both organs. In addition, antibodies produced by secondary
PCs were cleared from the system within weeks indicating
that secondary PCs are functionally short-lived. Inducing MBCs
that differentiate into secondary PCs by vaccination could
represent a novel pathway for efficient and rapid control of
infectious diseases by the induction of an early wave of high
affinity antibodies.
MATERIALS AND METHODS
Study Design
The goal of this study was to further characterize secondary
PCs, which were generated by MBCs after Ag challenge. To
achieve this, adoptive transfers in allotypic mice (Ly5.1/Ly5.2 and
IgHa/IgHb) were performed. This enabled us to study primary
and secondary immune responses in the same animal. All mice
were kept according to Cantonal Veterinary guidelines at the
central animal facility (Department for BioMedical Research) of
the University of Bern and controlled laboratory experiments
were performed in accordance with ethical principles and
guidelines of the Cantonal Veterinary Office Bern, Switzerland.
Animals were randomly assigned to the different groups. MBCs
were generated by VLP immunization of mice. The control naïve
mice remained untreated. At the same time, B cells were isolated
from memory and naive mice and transferred into recipients.
Upon immunization with VLPs, serum samples, spleens, and
BM were collected and subjected to ELISA, ELISPOT, and
FCM analysis. The investigators who performed the experiments,
assessed, analyzed, and quantified the results were not blinded
and aware of which group a sample was taken from. Individual
groups consisted of 4–5 mice. All experiments were performed
in at least 2 independent biological replicates, apart from
intracellular FCM analysis of PCs at day 6 after challenge. Data
were collected at previously determined time points. All data
were included in the analysis.
Mice
C57BL/6JRccHsd wildtype mice were purchased from Envigo
(Horst, The Netherlands). The IgHa (B6.Cg-Gpi1<a> Thy1<a>
Igh<a> (Stock No. 001317)) mouse strain was purchased
from the Jackson Laboratory (USA). We thank Prof. Annette
Oxenius for the kind donation of the Ly5.1 (B6.SJL-Ptprc<a>
Pepc<b>/BoyJ) mouse strain.
Antigen
The bacteriophage derived Qβ virus-like particles (VLPs) self-
assemble and enclose bacterial RNA during their production in
E. coli. Due to their particulate and repetitive structure, the VLPs
are highly immunogenic. The purification process is described
elsewhere (43).
Immunization
To induce primary immune responses and generate MBC against
the VLPs, mice were immunized intravenously (i.v.) with 50 µg
QβVLPs. To challenge adoptively transferredMBC or naive cells,
recipient mice were immunized with 50 µg Qβ VLPs i.v. For
intravenous administration the VLPs were formulated in 150 µl
sterile PBS.
Adoptive Transfer
MBCs were generated by immunization of congenic donor
mice (Ly5.1 or IgHa). At least 8 weeks after immunization
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donor mice were sacrificed and spleens isolated in RPMI media
containing 2% FCS and antibiotics. A single cell suspension of the
spleens was prepared and red blood cells were lysed using ACK
buffer (0.15M ammonium chloride, 0.01M potassium hydrogen
carbonate, pH 7.2–7.4). The splenocytes were PNA− and B220+
MACS purified. For PNA negative purification splenocytes were
labeled using PNA-biotin (Vector Labs, B-1075) and PNA+
cells were depleted by Strepravidin MicroBeads (Milteny Biotec,
130-048-101) according to the manufacturer’s protocol. Positive
selection using B220 MicroBeads (Milteny Biotec, 130-049-501)
was performed according to the manufacturer’s protocol.
Purified cells from 1/3 of a donor spleen (Ly5.1 or IgHa; ∼1–
3 × 106 cells) were adoptively transferred i.v. into congenic host
mice (Ly5.2 or IgHb). Control mice received PNA− and B220+
purified splenocytes from naïve congenic mice. One day after
MBC transfer host mice were challenged with 50 µg QβVLPs i.v.
Flow Cytometry (FCM)
For FCM staining tissues (spleen, BM, kidney, lymph nodes
(LN), liver, lung) of mice after adoptive transfer were isolated
in RPMI supplemented with 2% FCS and antibiotics and
single cell suspensions were prepared. Blood was collected in
phosphate buffer containing heparin (1–2 units/ml). Red blood
cells were lysed using ACK buffer prior to staining. Fc receptors
were blocked using an anti-CD16/32 antibody. Qβ specific
class switched (CS) B cells were identified as IgM, IgD, CD4,
CD8, GR1, CD11b, CD11c negative (all antibodies labeled with
phycoerythrin (PE)), and positive for B220 labeled with PE-
Cy7 and Qβ VLP labeled with Alexa Flour 488. To discriminate
Qβ specific PCs from Qβ specific activated and CS B cells,
surface immunoglobulins (Ig) of specific cells were blocked
using unlabeled Qβ VLPs. PCs were further stained with and
characterized as IgM, IgD, CD4, CD8, GR1, CD11b, CD11c
negative (all antibodies labeled with PE) and B220-PE-Cy7 low.
To detect Qβ specific PCs by intracellular staining of specific
Ig, splenocytes were permeabilized using FACS lysing solution
(BD, 349202) containing 0.04% Tween20 and stained with Alexa
Flour 488 labeled QβVLPs. The congenicmarker Ly5.1 (antibody
labeled with APC or PerCP-Cy5.5) identified all transfer derived
B cells. Dead cells were stained by the addition of propidium
iodide solution (PI, Sigma, 10µg/ml) directly before acquisition.
For detection of dead cells after fixation and permeabilisation, the
Fixable Viability Dye eFluor 520 (eBioscience, 65-0867-14) was
used according to the manufacturer’s instructions.
Qβ VLPs were labeled with the Alexa Flour 488 protein
labeling kit (Thermo Fisher Scientific, A10235) or Alexa Flour
647 NHS Ester (Thermo Fisher Scientific, A20006) according to
the manufacturer’s instructions.
Data acquisition was performed on a FACS Canto (BD) and
analyzed using FlowJo V10.1 (Flowjo, LLC, USA). All antibodies
were purchased from BD Biosciences and Biolegend.
ELISPOT
Spleens from mice after adoptive transfer were isolated and a
single cell suspension was prepared. To collect BM cells, tibia
and femur were flushed with RPMI media containing 2% FCS
and antibiotics. After red blood cell lysis with ACK buffer, cell
numbers of splenocytes and BM cells were determined using the
Cellometer mini (Nexcelom, USA). 5× 105 cells were seeded per
well on MAIPS Elispot plates (Millipore, MAIPS4510) previously
coated with 10µg/ml Qβ VLPs overnight at 4◦C and blocked
with 2% BSA in PBS for at least 2 h. After performing a 2-
fold dilution series cells were incubated for 5 h at 37◦C and
5% CO2. Subsequently cells were washed off and bound specific
antibodies produced by PCs were detected using a goat anti-
mouse IgG antibody (EY laboratories, AT-2306-2) followed by
a donkey anti-goat alkaline phosphatase secondary antibody
(Jackson Immunoresearch, 705-055-147). Spots were visualized
by the AP Conjugate Substrate Kit (BioRad, 1706432) and
counted using an EliSpot Reader (AID, Germany). The spot size
was quantified with the EliSpot 7.0 iSpot software of the EliSpot
Reader as the average surface area of the spot.
CFSE Proliferation
To analyse the proliferation of transferred cells, the donor cells
were labeled with CFSE (Biolegend, Cat No. 423801) after MACS
purification and before transfer into congenic hosts, according
to the manufacturer’s protocol. FCM staining was carried out
similarly as described above. In this case, Qβ specific CS B cells
were detected with VLPs labeled with Alexa Flour 647.
Splenocyte Cell Culture
Spleens frommice that had receivedmemory or naïve B cells were
isolated 5 and 6 days after VLP challenge. A single cell suspension
of splenocytes was prepared. After red blood cell lysis with ACK
buffer, cell numbers of splenocytes were determined using the
Cellometer mini (Nexcelom, USA). 10 × 106 cells were seeded
in 1ml RPMI media containing 10% FCS and antibiotics per
well in 24 well plates (Falcon Multiwell, Corning). The cells were
incubated for 72 h at 37◦C and 5% CO2. Cell supernatants were
harvested and the antibody content determined by ELISA.
ELISA
Serum samples were obtained from blood collected at the
indicated time points during experiments using Microtainer
tubes (BD, 365967). Corning half area 96 well-plates were coated
with 50 µl of 1µg/ml Qβ VLPs overnight at 4◦C. Sera were
1:10 pre-diluted and 1:4 further serial diluted to analyse a
total of 7 dilutions per sample. Qβ specific antibodies were
detected using mouse anti-mouse IgG for both allotypes. IgHa-
specific (biotin ms anti-ms IgG1[a] (10.9), biotin ms anti-ms
IgG2a[a] (8.3) from BD) and IgHb-specific (biotin ms anti-ms
IgG1[b] (B68-2), biotin ms anti-ms IgG2a[b] (5.7) from BD)
antibodies were detected using horseradish peroxidase (HRP)
labeled streptavidin (Dako).
Cell supernatants were used undiluted and a 1:2 serial
dilution was performed. An anti-Qβ monoclonal antibody
(purified from hybridoma cells) was used as a standard to
quantify specific antibodies in the supernatants. Qβ specific
antibodies were detected using goat anti-mouse IgG-HRP
(Jackson ImmunoResearch, 115-035-071).
The absorbance readings of the tetramethylbenzidine (TMB)
color reaction at 450 nm for the serum samples were interpreted
as OD50 antibody titers. The OD50 antibody titers are defined
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as the reciprocal of the dilution that reaches half of the OD max.
The anti-Qβ monoclonal antibody standard curve was used to
calculate antibody concentrations in the cell supernatants.
Avidity ELISA
Serum samples were obtained from blood collected at the
indicated time points during experiments using Microtainer
tubes (BD, 365967). Corning half area 96 well-plates were coated
with 50 µl of 1µg/ml Qβ VLPs overnight at 4◦C. Sera of the
different time points were applied with a 1:20 pre-dilution and
1:4 further serial diluted. After 1 h incubation, the sera were
washed off and the plates washed 3 times 5min either with
7M urea in PBST (PBS containing 0.05% tween 20) or PBST
only. Qβ specific antibodies were detected using mouse anti-
mouse IgG for both allotypes. IgHa-specific (biotin ms anti-
ms IgG1[a] (10.9), biotin ms anti-ms IgG2a[a] (8.3) from BD)
and IgHb-specific (biotin ms anti-ms IgG1[b] (B68-2), biotin ms
anti-ms IgG2a[b] (5.7) from BD) antibodies were detected using
horseradish peroxidase (HRP) labeled streptavidin (Dako). The
absorbance readings of the tetramethylbenzidine (TMB) color
reaction at 450 nm served as basis for avidity index calculation.
The avidity index (AI) was calculated by AIx = OD (dilution x)
+ urea / OD (dilution x)–urea.
Antibodies/Reagents
Antibody/reagent Clone Company Conjugate Detection Catalog number
goat anti-ms IgG polyclonal EY laboratories donkey anti-goat alkaline phosphatase (AP) AT-2306-2
donkey anti-goat AP polyclonal Jackson ImmunoResearch AP 705-055-147
anti-ms IgG1[a] 10.9 BD biotin Streptavidin HRP (Dako) 553500
anti-ms IgG2a[a] 8.3 BD biotin Streptavidin HRP (Dako) 553533
anti-ms IgG1[b] B68-2 BD biotin Streptavidin HRP (Dako) 553502
anti-ms IgG2a[b] 5.7 BD biotin Streptavidin HRP (Dako) 553504
goat anti-ms IgG polyclonal Jackson ImmunoResearch HRP 115-035-071
anti-ms CD16/32 2.4G2 BD 553142
anti-ms IgM polyclonal Jackson ImmunoResearch PE 115-116-075
anti-ms IgD 11-26c (11-26) eBioscience PE 12-5993-83
anti-ms CD8a 53-6.7 BD PE 553032
anti-ms CD4 H129.19 BD PE 553653
anti-ms CD11b M1/70 BD PE 553311
anti-ms CD11c HL3 BD PE 553802
anti-ms GR1 RB6-8C5 BD PE 553128
anti-ms B220 RA3-6B2 BD PE-Cy7 552772
anti-ms CD45.1 A20 eBioscience APC 17-0453-82
anti-ms CD45.1 A20 Biolegend PerCP/Cy5.5 110727
anti-ms CD38 90 Biolegend PerCP/Cy5.5 102722
Anti-ms IgG Polyclonal eBioscience Biotin Streptavidin APC/Cy7 13-4013-85
Peanut Agglutinin (PNA) Vector Laboratories Biotin Streptavidin APC/Cy7 B-1075
Streptavidin HRP Dako HRP P0397
Streptavidin APC/Cy7 BD APC/Cy7 554063
Fixable Viability Dye eFluor 520 eBioscience eFluor 520 65-0867-14
Statistics
Statistical analysis was performed using GraphPad Prism
Version 7.01 (GraphPad Software, USA). Statistically significant
differences between two groups were calculated using unpaired
t-tests. Statistically significant differences between more than
2 groups were determined using a one-way ANOVA followed
by Tukey’s or Sidak’s multiple comparisons test. Statistical
significance was defined as p < 0.05. The best fitting line was
calculated by linear regression.
RESULTS
Memory B Cell Derived Secondary PCs
Produce Antibodies of Higher Avidity
We have previously shown that MBCs are generated against
Qβ VLPs in a T cell-dependent manner (35, 38, 39, 44, 45).
During secondary responses, these MBCs do neither extensively
proliferate nor join GC reactions (35). T cell help, however,
is essential for low-level MBC proliferation but dispensable
for differentiation to secondary PCs during secondary immune
responses (44). To reveal insights in the mechanism and kinetics
of secondary PC formation from MBCs after antigenic re-
stimulation, adoptive transfer experiments using congenic mice
were performed (Figure 1A). To this end, MBCs were generated
by immunizing donor mice (Ly5.1 or IgHa) with 50 µg Qβ
VLPs. Eight weeks post immunization, splenocytes from donor
mice were isolated and PNA− and B220+ MBCs were purified
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by MACS, excluding transfer of GC B cells. Splenocytes from
naïve mice were subjected to the same treatment and served as
controls. We have previously shown that the presence of memory
T follicular helper cells does not influence the MBC response (35,
44). Therefore, purified MBCs were transferred alone. Donor-
derived (Ly5.1+) MBCs were shown to preferentially home to
secondary lymphoid organs, namely lymph nodes (LN), and
spleen (Figure S1A) and themajority of Qβ-specific donorMBCs
were found in the spleen (Figure S1B).
To analyse the humoral immune response after memory or
naïve B cell transfer and Qβ VLP challenge, immunoglobulin
heavy chain allotype mice were used as shown in Figure 1A.
MBCs were induced in donor mice (IgHa) and adoptively
transferred into recipient mice (IgHb). The recipient mice were
challenged with QβVLPs 1 day after the transfer and splenocytes,
BM as well as serum were collected at the indicated time points
to determine CS B cells (outlined in Figure 1B), PCs (outlined
in Figure 1C) as well as anti-Qβ antibody titers (Figure 2).
The donor derived secondary response was discriminated from
the host’s primary response using allotype specific detection
antibodies for IgG1 and IgG2a in ELISA, as these are the main
isotypes induced by Qβ immunization (46) (Figure 2). Donor
derived antibodies after MBC transfer started to rise from day
4 after challenge, peaked around day 6 and then declined until
day 20 (Figure 2A). In contrast, host antibody titers only started
rising from day 6 and peaked at day 12. The peak titer of
the host antibodies was lower than from the donor, indicating
that MBC-derived secondary PCs dominated the early response.
In addition, the relatively rapid decline of the donor-derived
antibody titer is a clear indicator that the functional response of
secondary PCs is unexpectedly short-lived.
Whether donor-derived MCBs could undergo a tertiary
response was assessed next. To this end, recipient mice were
challenged a second time with VLPs on day 61. Surprisingly,
only the host-derived but not the donor-derived antibody
response could be boosted, demonstrating that MBCs cannot
participate twice in a humoral response after challenge with
VLPs (Figure 2A). This suggests that essentially all MBCs
generated against VLPs instantly differentiated to secondary PCs
after re-stimulation without supplying a new MBC population.
As expected, transferred naïve donor cells did not respond
to the VLP challenge, as they also did not engage in the
primary response (Figure 2B). Of note, host antibody levels
were elevated after naïve B cell transfer compared to the host
response in presence of MBCs (Figures 2A,B). This indicates
that the presence of MBC derived secondary PCs suppresses the
hosts humoral response after VLP challenge, confirming earlier
observations (35).
In order to analyze the antibody avidity of the secondary
antibody response, a modified ELISA was performed. For this
purpose, low avidity antibodies were dissociated by treatment
with 7M urea. Only high avidity antibodies remain bound under
these conditions (47, 48). Comparing the OD values of urea vs.
PBS treated sera, an avidity index was calculated. The primary
response antibodies of the host started to increase in avidity
between day 6 and 9 after immunization (Figures 2C,D). The
avidity increase proceeded until day 21. In marked contrast,
avidity of antibodies derived from secondary PCs was high
as of day 4 after challenge and did not further increase
(Figure 2C). Thus, secondary PCs are not only superior in
antibody production but also in antibody avidity.
MBCs Do Not Extensively Proliferate
Before Differentiating to Secondary PCs
Upon Cognate Antigen Challenge
To be able to study proliferation of MBCs before differentiation
to PCs, purified B cell populations were labeled with CFSE
prior to adoptive transfer. One day after transferring the MACS
purified and CFSE labeled B cells, congenic recipient mice (Ly5.2)
were challenged with 50 µg Qβ VLPs. Flow cytometric analysis
of the Qβ specific CS B cells (Figure 1B) showed that all MBCs
had proliferated as essentially no CFSE+ Ly5.1+ Qβ-specific cells
could be observed (Figure 3A, right histogram). Nevertheless,
there was a robust number of CFSE+, Ly5.1+, B220+ cells,
which were not specific for Qβ, demonstrating survival of labeled
cells upon adoptive transfer (Figure 3A, left histogram). The
proliferation seen in this subset could be attributed to bystander
proliferation or plasma blasts generated after proliferation and
differentiation of MBCs, which had already downregulated
surface BCR expression but are still B220+. Thus, essentially all
MBCs proliferated but this proliferation was not extensive and
of short duration, as few MBCs accumulated but rather rapidly
differentiated into secondary PCs (see below).
Transferred MBCs Are Detectable in the
Specific B Cell Compartment Only at Early
Time Points Upon VLP Challenge
In order to follow theMBC response upon transfer and challenge,
the specific CS B cells were analyzed in the spleen by flow
cytometry (FCM). VLP-specific CS B cells of donor (Figure 3B)
and host (Figure 3C) origin were visualized as defined in
Figure 1B and viable (Figures S2A,B). An increased number of
Qβ specific donor derived cells was found, when MBCs were
transferred compared to naïve B cell transfer on day 4 and
5 after VLP challenge (Figure 3B). This difference was more
pronounced on day 5 but was already absent on day 6 post
immunization. The host response in the CS B cell compartment
was comparable between memory and naïve B cell transfer on
day 4 and 5 after challenge (Figure 3C). However, the host B cell
response seemed to be slightly impaired at day 6 when MBCs
were present suggesting that MBCs suppress the response of
the naïve host B cells (Figure 3C). This was consistent with the
reduced host antibody titer in the presence of MBCs observed
above (Figures 2A,B).
Secondary PCs Are Rapidly Induced but
Are Functionally Short-Lived
To characterize the secondary PC population ELISPOT assays
of spleen and BM were performed. As suggested by the
antibody responses, secondary PCs occurred very promptly
and reached high numbers 4 days after Ag challenge but the
population rapidly contracted within the next 2 days (Figure 4A).
Similar observations were made in the BM (Figure 4B). Besides
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FIGURE 1 | Adoptive transfer of Qβ VLP specific or naïve B cells and flow cytometric analysis of Qβ specific CS B and plasma cells in the spleen. (A) Congenic mice
(Ly5.1 or IgHa) were immunized with 50 µg Qβ VLPs i.v. Eight weeks after immunization spleens of immunized and naïve mice were isolated and PNA− B220+ MACS
purified cells were transferred into host mice (Ly5.2 or IgHb). Recipient mice were immunized with 50 µg Qβ VLPs i.v. 1 day after the transfer. Spleens, bone marrow,
and serum were taken at several time points after challenge. (B) Representative FCM plots for the gating strategy to identify Qβ specific CS B cells in the spleen 5
days after immunization. B220+ cells not expressing IgM, IgD, CD4, CD8, CD11b, CD11c, or GR1 were analyzed for their binding of labeled Qβ VLPs. The congenic
Ly5 marker was used to discriminate transfer from host derived CS B cells. (C) Representative FCM plots for the gating strategy to identify Qβ specific PCs in the
spleen 5 days after immunization. B220low cells not expressing IgM, IgD, CD4, CD8, CD11b, CD11c, or GR1 were analyzed for their intracellular binding of labeled Qβ
VLPs. The congenic Ly5 marker was used to discriminate transfer from host derived PCs cells.
ELISPOT analysis, PCs were enumerated by FCM, where the
same pattern emerged. Secondary PCs occurred rapidly and
peaked between days 4 and 5 but were largely absent by day 6
(Figure 4C). Thus, secondary PCs are induced within a few days
but appear to be short-lived. As observed above for the CS B
cells, the PC compartment of the host is similar on days 4 and
5, whereas it is slightly decreased on day 6 when MBCs were
transferred (Figure 4D).
Transfer Derived Secondary PCs Show
Enhanced Capacity to Produce Antibodies
in Spleen and BM
As previously described, one hallmark for secondary PCs is their
enhanced capacity to produce antibodies after cognate antigen
challenge (35). An indicator for enhanced antibody production
during MBC responses was the spot size in ELISPOT assays,
as it is correlating with the amount of antibodies produced by
one PC. Representative images of ELISPOTs from splenocytes
after memory or naïve B cell transfer and challenge with VLPs
are shown (Figure 5A). Every spot on the plate represents one
Qβ specific PC and the spot diameter correlates the amount of
antibody that is produced by one PC. Spot diameters of specific
PC populations in spleen and BM were analyzed 4–6 days after
adoptive transfer of memory or naïve B cells that were challenged
with VLPs. The spot diameter from spleen and BM was always
greater when MBCs were transferred. The most significant
difference however was observed on day 5 after Qβ VLP
challenge, representing the peak of the secondary PC response
(Figures 5B,C). This observation was confirmed by FCM on day
5 after MBC transfer and challenge, as the mean fluorescent
intensity (MFI) of intracellular anti-IgG binding was increased
in donor-derived compared to host PCs (Figure 5D). As the
MFI of intracellular Qβ binding correlated with the amount of
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FIGURE 2 | Memory B cell derived secondary PCs produce antibodies of higher avidity. (A) MBC responses were initiated by vaccinating IgHa mice with 50 µg Qβ
VLPs. After 8 weeks, PNA− and B220+ MACS purified B cells from memory (A) or naïve (B) donor mice were transferred into congenic recipients (IgHb). Recipient
mice were challenged with 50 µg Qβ VLPs 24 h and 61 days after the transfer. The anti-Qβ IgG1 and IgG2a antibody titers in the serum were determined by ELISA on
days 0, 2, 4, 6, 9, 12, 15, 21, 42, 61, 65, 68, and 85. Using Ha and Hb allotype specific detection antibodies, donor (IgHa), and host (IgHb) responses were
discriminated. To determine the avidity index of IgGs in the sera after memory (C) or naïve (D) B cell transfer and VLP challenge, a modified ELISA was performed.
Mean with SEM. P values were calculated using an unpaired t test. n = 4 mice per group. Data representative of 2 independent experiments. *p < 0.05, **p < 0.01,
***p < 0.001, ****p < 0.0001.
intracellular anti-IgG binding it can serve as a surrogate for the
amount of antibody present inside PCs (Figure 5D). The MFI
of intracellular Qβ binding was significantly increased 4 and
5 days after challenge with Qβ when MBCs were transferred
(Figure 5E). Taken together the results of the spot size and
intracellular staining of spleen and BM-derived PCs indicated
that secondary PCs produced increased amounts of antibodies.
Both spot size and intracellular staining with Qβ-VLPs may
not linearly correlate with antibody production. To estimate
the amount of antibodies produced by secondary vs. primary
PCs more directly, splenocytes were collected and cultured from
mice 5 and 6 days after adoptive transfer and VLP challenge.
Whole splenocytes were seeded into 24 well-plates for 72 h
and frequencies of specific PCs were quantified by FCM at
the beginning of the culture. The amount of anti-Qβ antibody
in cell culture supernatants of splenocytes harvested 5 and 6
days after challenge was ∼30 fold increased when MBCs were
transferred, again demonstrating that secondary PCs produced
elevated antibody levels (Figure 5F). The total amount of anti-
Qβ antibody decreased from day 5 to day 6 after memory transfer
(Figure 5F) further demonstrating their short lived nature.
Nevertheless, the amount of specific antibody per PC stayed
the same (Figure 5G). After naïve transfer, on the contrary, the
amount of antibody per PC increased over time, as the primary
response evolved (Figure 5G). This massively increased protein
production by secondary PCs illustrates the stress these PCs may
be exposed to, probably resulting in the short live span.
DISCUSSION
Long-lived PCs are crucial for sustained immune protection
through secretion of specific antibodies (24). However, PCs do
not always become long-lived during infection or vaccination
because most of the PCs die early during the immune response.
In fact, during primary immunogenicity studies using VLPs, we
observed that the PC population in spleen emerged on day 4,
peaked at day 7 and subsequently declined rapidly, followed
by a phase of more stable PC frequencies (35). Hence, most
PCs formed initially against Qβ are short-lived (41). This short
lifespan may be a result of the irrevocable cell cycle arrest which
PCs usually enter and therefore cannot maintain a cellular pool
by means of proliferation. In contrast, the state of irreversible cell
cycle quiescence must be controlled by mechanisms to enable
long-term PC survival. Moreover, the ephemerality of the early
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FIGURE 3 | MBCs do not extensively proliferate before differentiating to secondary PCs upon cognate antigen challenge. PNA−, B220+ MACS purified cells from Qβ
immune (8 weeks post immunization) or naïve Ly5.1 mice were labeled with CFSE and transferred into congenic hosts. Recipient mice were challenged 24 h later with
50 µg Qβ VLPs i.v. (A) Representative FCM plot to identify Qβ specific CS B cells in the spleen 5 days after challenge. B220+ cells negative for IgM, IgD, CD4, CD8,
CD1b, CD11c, and GR1 were analyzed for their Qβ binding. CFSE dilution was examined to prove proliferation of donor derived cells (Ly5.1+). (B,C) Number of Qβ
specific CS B cells on day 4, 5, and 6 after challenge identified by FCM as B220+, negative for IgM, IgD, CD4, CD8, CD11b, CD11c, GR1, and binding Qβ. Qβ
specific donor (B) derived cells were distinguished from host derived cells (C) using the Ly5 congenic marker. Mean with SEM. P values were obtained using a
one-way ANOVA followed by Tukey’s multiple comparisons test. **p < 0.01. n = 4 mice per group. Data representative of at least 2 independent experiments.
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FIGURE 4 | Transfer of memory B cells leads to an increased number of PCs, which are rapidly induced but short-lived. Congenic Ly5.1 mice were immunized with
Qβ VLPs to generate MBCs. Eight weeks after the immunization PNA−, B220+ MACS purified cells from memory or naïve mice were transferred into congenic hosts.
One day after the transfer, recipient mice were challenged with Qβ VLPs and the anti-Qβ PC response in spleen and BM was elucidated by ELISPOT and FCM.
Number of Qβ specific PCs in spleen (A) and BM (B) on day 4, 5, and 6 after challenge determined by ELISPOT. FCM analysis of Qβ specific PCs within the B220low,
IgM, IgD, CD4, CD8, CD11b, CD11c, and GR1 negative compartment, by intracellular Qβ binding after membrane permeabilisation. Qβ specific donor derived PCs
(C) were distinguished from host derived PCs (D) using the Ly5 congenic marker. Mean with SEM. P values were obtained using a one-way ANOVA followed by
Tukey’s multiple comparisons test. *p < 0.05, **p < 0.01, ***p < 0.001. n = 4 mice per group. Data representative of at least 1–2 independent experiments.
PCs could also be due to ER stress caused by themassive antibody
production. Cell intrinsic constraints like unfolded protein
response (UPR) and autophagy can rescue PCs from cell death
but the cells additionally require sufficient nutrients, external
survival signals and a survival niche (30, 49–52). Long-lived PCs
are found in both the spleen and BM. However, the numbers of
niches is finite, thus restricting the number of PCs with access to
them (1). In fact, most VLP specific PCs reaching the BM do not
survive as the number of PCs rapidly declines initially also in the
BM (45). The constant competition for space and survival signals
of PCs within the BMmay provide an opportunity to manipulate
PC survival for long-term antibody production upon vaccination
as well as for therapies of malignant PC diseases (53). Moreover,
CD28 has been shown to be expressed by human and mouse
PCs (54, 55). Engagement of CD28 with CD80/CD86 derived
from cellular partners in the PC niche was demonstrated to be
important for BM long-lived PC survival, half-life and sustained
antibody responses. Downstream signaling of CD28 induces
BLIMP1 upregulation and is therefore involved in regulating PC
differentiation and maintenance (55, 56). Furthermore, CD28
was shown to regulate glycolysis in long-lived PCs providing
glycolytic end products for oxidative energy production and
biosynthesis (57). Additionally CD28 regulated mitochondrial
metabolism and respiration which favored survival of long-lived
PCs (58, 59). In contrast to long-lived PCs, CD28 exhibited a
higher activation threshold in short-lived PCs and therefore had
no positive impact on their survival (55). Together with limited
access to CD80/CD86molecules derived from BMPC niche cells,
the increased threshold of CD28 activation could be reasons for
the short-lived nature of the secondary PCs. We are currently
assessing a potential role of CD28 in the lifespan of primary and
secondary PCs.
A population of MBCs is maintained after the decline of
immune responses and may be activated upon re-infection to
rapidly differentiate into PCs, which secrete antibodies. However,
it has also been reported thatMBCs can re-enter GCs and interact
with T follicular helper cells shaping the immune response and
generating a new pool of MBCs. In analogy to memory T
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FIGURE 5 | Transfer derived secondary PCs show enhanced capacity to produce antibodies in spleen and BM. PNA−, B220+ MACS purified cells from Qβ immune
(8 weeks post immunization) or naïve Ly5.1 mice were transferred into congenic hosts. One day after the transfer, recipient mice were challenged with 50 µg Qβ VLPs
i.v. Splenocytes and BM cells were analyzed by ELISPOT and FCM on day 4, 5, and 6 after challenge. (A) Representative images of anti-Qβ ELISPOTs on day
5 after challenge in the spleen. Quantification of spot diameter in spleen (B) and BM (C) on day 4, 5, and 6 after challenge. (D) Quantification of mean intracellular Qβ and
(Continued)
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FIGURE 5 | anti-IgG binding of donor and host derived PCs on day 5 after memory transfer and challenge. (E) Quantification of mean intracellular Qβ-VLP binding of
donor and host derived PCs after memory transfer. (F,G) Splenocytes were isolated 5 and 6 days after challenge and cultured for 3 days in vitro. Secreted antibodies
in the cell supernatant were determined by ELISA. (F) Amount of anti-Qβ antibody secreted during the 72 h splenocyte cell culture. (G) Amount of specific antibodies
produced per PC 5 and 6 days after memory or naïve cell transfer and challenge. Mean (B,C,F,G) or geometric mean (D,E) with SEM. P values were obtained using a
one-way ANOVA followed by Tukey’s multiple comparisons test. *p < 0.05, **p < 0.01, ***p < 0.001. n = 4 mice per group (A–C,E–G), n = 3 mice per group (D).
Data representative of 1–2 independent experiments.
cells, these two different effector functions of MBCs define two
distinct cellular compartments: the effector MBCs differentiating
into PCs for rapid antibody production and the central MBCs
playing a role in re-initiating the GC response and maintaining
the MBC pool (60). The secondary PCs described herein are
derived from effector MBCs that were generated by a single
round of immunization using Qβ-VLP. B cell intrinsic toll-like
receptor (TLR) 7 stimulation was shown to be essential for MBC
generation that were capable of differentiating to secondary PCs
(61). Intriguingly, VLP specific MBCs only responded a single
time to Ag re-stimulation, namely by terminal differentiation
into short-lived PCs. These secondary PCs were B220− and no
longer carried their Ig on the surface and therefore could not
be further stimulated with the Ag. Baptista et al. studied PC
differentiation in response to innate stimuli in the absence of
antigen and observed that TLR9 signaling by CpG failed to
differentiate follicular B cells into PCs whereas TLR4 stimulation
by lipopolysaccharide (LPS) induced antibody production, PC
surface markers such as CD138 and canonical transcription
factors like IRF4, BLIMP1 or XBP1 (62). Furthermore, ligation
of BCR and TLR7 was shown to drive PC differentiation
(63, 64). Therefore, the downregulation of BCR and B220
expression and increased antibody production seen in response
to MBC re-stimulation with VLPs containing bacterial RNA
are clear signs of PC differentiation. Nevertheless, we never
found a homogenous CD138+ cell population using VLPs for
vaccination. Consequently, further work needs to be done to
determine the expression of classical PC transcription factors and
surface markers to characterize the phenotype of secondary PCs
in more detail.
The avidity of the antibodies secreted by secondary PCs
was very high at early time points after immunization, a level
which antibodies generated during a primary response only
reached by day 20 upon VLP immunization. This finding is
consistent with the notion that secondary PCs derive fromMBCs
which have undergone avidity maturation in a GC reaction
(45). Thus, secondary PCs provide the host with a rapid wave
of high-avidity antibodies. The great amount of VLP-specific
IgG, which is present early during the recall response, is most
likely responsible for the suppression of the host response. Link
et al. demonstrated that VLPs complexed to specific IgGs were
taken up by macrophages in the subcapsular sinus and did
not efficiently reach B cell follicles and follicular dendritic cells,
leading to antigen deprival for naïve B cell activation (65).
Surprisingly, secondary PCs did not have a long functional
lifespan, neither in spleen nor in BM. In fact, most of them
disappeared from lymphoid organs within 6 days after Ag re-
stimulation. The dominant pool of long-lived PCs induced in
the presence of MBC was derived from primary B cells. The
early death of secondary PCs is probably a consequence of the
enhanced antibody production, which increases cellular stress
levels. Access to niches seems less important, as numbers of
primary and secondary PCs are similar at day 6 after challenge,
and yet only primary PCs become long-lived. The increased
antibody production in secondary PCs more likely accounts
for the short lifespan due to increased ER stress as well as
accelerated demand for nutrients. The fact that secondary
PCs produce at least 30 times more antibody than primary
PCs underscores this point. It has been shown that PCs are
able to adapt their metabolism according to the changing
environment, but secondary PCs may be induced too quickly
to produce very large amounts of antibodies, to be able to
adapt their metabolism sufficiently. In addition, they may not
live long enough to actually find a niche allowing their long-
term survival. In this respect, secondary PCs behave more like
innate cells, which usually respond very rapidly but are short-
lived as well. In terms of surface marker and transcription factor
expression, secondary PCs most likely do not differ extensively
from other PC populations. However, there are substantial
functional differences.
The fact that during viral infection all MBCs differentiate
into functionally short-lived secondary PCs has interesting
biological implications as it keeps the antibody repertoire flexible
and adaptable to the changing world of pathogens, as e.g.,
influenza viruses. Secondary PCs produce an early wave of high
avidity antibodies specific for the strain of pathogen previously
encountered. Under this early protective antibody umbrella,
naïve B cells are activated, initiate a novel GC reaction and
generate high avidity PCs andMBCs for the current version of the
pathogen. This mechanism ensures that the antibody repertoire
is not frozen to the specificity for a single version of a pathogen
but remains adaptable to their evolution. In this respect, the here
presented mechanism ensures that original antigenic sin does not
limit the dynamics and broadness of the antibody repertoire too
extensively (25, 66, 67).
In summary, we demonstrate here that upon challenge with
viral particles MBCs differentiate rapidly into secondary PCs,
providing the host with an early wave of high avidity antibodies.
Thus, induction of effector MBCs, which can provide rapid
and effective protection by differentiating into secondary PCs,
may be a promising alternative that should be considered in
vaccine development.
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